cancer-treatment

Documents about cancer-treatment

• Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer#217018ClinicalTrials.gov
• Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.#227993NCBI PubMed Central
• External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma#252974ClinicalTrials.gov
• A computational framework for optimizing radioiodine therapy protocols in metastatic thyroid cancer#273923HAL (France)
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment#283098ClinicalTrials.gov
• HER2-Ultralow: Prevalence, Characteristics, and Treatment Choices Among Advanced Breast Cancer Patients With Tumors Initially Scored as IHC 0.#312635NCBI PubMed Central
• An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)#341990ClinicalTrials.gov
• Large language models for breast cancer treatment planning: a blinded real-world evaluation of DeepSeek, ChatGPT, and oncologist recommendations.#371548NCBI PubMed Central
• Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy#398312ClinicalTrials.gov
• IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors#424190ClinicalTrials.gov
• Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract#633734ClinicalTrials.gov
• Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers#651242ClinicalTrials.gov
• Dose-dense anthracycline- and taxane-based chemotherapy remains the preferred treatment for selected patients with high-risk early breast cancer#652951IRIS
• Causal AI for cancer immunotherapy: a narrative framework review of target trial emulation, treatment-effect learning and clinical translation.#653365NCBI PubMed Central
• A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors#668833ClinicalTrials.gov
• Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia#804841ClinicalTrials.gov
• Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence#801079ClinicalTrials.gov
• A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer#195518ClinicalTrials.gov
• Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer#300239ClinicalTrials.gov
• A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression#311115ClinicalTrials.gov
• A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)#417527ClinicalTrials.gov
• Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer?#801093ClinicalTrials.gov
• Post-treatment serum interleukin-6 is independently associated with disease progression in patients with advanced non-small cell lung cancer and coexisting COPD: a multicenter real-world cohort study#673302ARPHA OAI-PMH Endpoint
• Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial#802756ClinicalTrials.gov
• Impact of Clonal Hematopoiesis of Indeterminate Potential on Treatment Response and Tumor Microenvironment in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.#3963NCBI PubMed Central
• Patient perspectives on the use of artificial intelligence to support treatment decision making in renal cancer: findings from the KATY project.#165664NCBI PubMed Central
• Pay It Forward: Analysis of a novel peer-to-peer support initiative for individuals receiving treatment for head and neck cancer.#209330NCBI PubMed Central
• Bowel cancer care in individuals with an intellectual disability: a population-based cohort study of symptoms, diagnostic pathways, treatment and survival.#213867NCBI PubMed Central
• Generative AI‐Driven CNN Framework for Enhanced Lung Cancer Detection, Prediction, and Treatment: A Novel Approach to Overcoming AI Limitations.#219131NCBI PubMed Central
• Quality of life-before and after treatment. A quantitative study of women with breast cancer receiving neoadjuvant or adjuvant chemotherapy#231427Europe PMC
• Built environment (BE) and cancer: a systematic review of the BE's impact during the treatment journey and patient outcomes.#235956NCBI PubMed Central
• SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC#245495ClinicalTrials.gov
• Treatment terminations during radiation therapy: A retrospective descriptive single-center analysis#258680PLOS
• Fear of Progression in Pediatric Cancer Patients and Their Parents: Trajectories, Prevalence, and Correlates Across Acute Treatment and Follow-Up Care.#266801NCBI PubMed Central
• Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer#311126ClinicalTrials.gov
• Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer#314335ClinicalTrials.gov
• Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors#326130HAL (France)
• Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unit.#342344NCBI PubMed Central
• Supplementary Material for: Abemaciclib-associated psychosis: a case report of a rare neuropsychiatric adverse effect during breast cancer treatment#363840Figshare
• Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment#377411ClinicalTrials.gov
• Integrating polyphenols and exercise in cancer prevention, treatment, and rehabilitation: cellular and molecular mechanisms linking the injury-recovery-musculoskeletal resilience axis.#402469NCBI PubMed Central
• Survival beyond treatment: patterns and determinants of disease-free survival in cervical cancer at a tertiary care center in India.#402609NCBI PubMed Central
• Psychological and social factors influencing quality of life during treatment in active breast cancer patients and psychological interventions: a systematic review.#445964NCBI PubMed Central
• MRI-Based Structured Assessment of Treatment Response in Rectal Cancer After Total Neoadjuvant Therapy: Correlation With Surgical and Pathological Outcomes.#480937NCBI PubMed Central
• Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors.#683087ClinicalTrials.gov
• Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy#806623ClinicalTrials.gov
• Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma#806638ClinicalTrials.gov
• Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC#807994ClinicalTrials.gov
• Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases#810466ClinicalTrials.gov
• Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer#162449ClinicalTrials.gov